TASIGNA
NOVARTIS PHARMACEUTICALS CANADA INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is TASIGNA discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that TASIGNA 50MG has been permanently discontinued (last updated November 7, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is TASIGNA not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
REDDY-NILOTINIB
DR REDDY'S LABORATORIES LTD
Other Products
TASIGNA
NOVARTIS PHARMACEUTICALS CANADA INC
APO-NILOTINIB
APOTEX INC
PMS-NILOTINIB
PHARMASCIENCE INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02481715
Strength
50MG
Dosage Form
CAPSULE
Route
ORAL
Compare with another product →
Shortage History
Other Products from NOVARTIS PHARMACEUTICALS CANADA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
2.5MG · DIN 02369257
10MG · DIN 02339528
5MG · DIN 02339501
7.5MG · DIN 02450267
2MG · DIN 02425645
5MG · DIN 02425661
3MG · DIN 02425653
140MG · DIN 02487306
70MG · DIN 02479613
0.1% · DIN 00893560
100MG · DIN 02381559
1000MG · DIN 02381567